Literature DB >> 8326013

Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.

R C Bonadonna1, S Del Prato, M P Saccomani, E Bonora, G Gulli, E Ferrannini, D Bier, C Cobelli, R A DeFronzo.   

Abstract

Insulin resistance for glucose metabolism in skeletal muscle is a key feature in non-insulin-dependent diabetes mellitus (NIDDM). Which cellular effectors of glucose metabolism are involved is still unknown. We investigated whether transmembrane glucose transport in vivo is impaired in skeletal muscle in nonobese NIDDM patients. We performed euglycemic insulin clamp studies in combination with the forearm balance technique (brachial artery and deep forearm vein catheterization) in six nonobese NIDDM patients and five age- and weight-matched controls. Unlabeled D-mannitol (a nontransportable molecule) and radioactive 3-O-methyl-D-glucose (the reference molecular probe to assess glucose transport activity) were simultaneously injected into the brachial artery, and the washout curves were measured in the deep venous effluent blood. In vivo transmembrane transport of 3-O-methyl-D-glucose in forearm muscle was determined by computerized analysis of the washout curves. At similar steady-state plasma concentrations of insulin (approximately 500 pmol/liter) and glucose (approximately 5.15 mmol/liter), transmembrane inward transport of 3-O-methyl-D-glucose in skeletal muscle was markedly reduced in the NIDDM patients (6.5 x 10(-2) +/- 0.56 x 10(-2).min-1) compared with controls (12.5 x 10(-2) +/- 1.5 x 10(-2).min-1, P < 0.005). Mean glucose uptake was also reduced in the diabetics both at the whole body level (9.25 +/- 1.84 vs. 28.3 +/- 2.44 mumol/min per kg, P < 0.02) and in the forearm tissues (5.84 +/- 1.51 vs. 37.5 +/- 7.95 mumol/min per kg, P < 0.02). When the latter rates were extrapolated to the whole body level, skeletal muscle accounted for approximately 80% of the defect in insulin action seen in NIDDM patients. We conclude that transmembrane glucose transport, when assessed in vivo in skeletal muscle, is insensitive to insulin in nonobese NIDDM patients, and plays a major role in determining whole body insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8326013      PMCID: PMC293636          DOI: 10.1172/JCI116592

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

1.  Substrate regulation of the glucose transport system in rat skeletal muscle. Characterization and kinetic analysis in isolated soleus muscle and skeletal muscle cells in culture.

Authors:  S Sasson; E Cerasi
Journal:  J Biol Chem       Date:  1986-12-25       Impact factor: 5.157

2.  In vitro autoregulation of glucose utilization in rat soleus muscle.

Authors:  S Sasson; D Edelson; E Cerasi
Journal:  Diabetes       Date:  1987-09       Impact factor: 9.461

3.  The relative proportions of fat, muscle and bone in the normal human forearm as determined by computed tomography.

Authors:  R J Maughan; J S Watson; J Weir
Journal:  Clin Sci (Lond)       Date:  1984-06       Impact factor: 6.124

4.  Adipose tissue glucose transporters in NIDDM. Decreased levels of muscle/fat isoform.

Authors:  M K Sinha; C Raineri-Maldonado; C Buchanan; W J Pories; C Carter-Su; P F Pilch; J F Caro
Journal:  Diabetes       Date:  1991-04       Impact factor: 9.461

5.  Decreased expression of glucose transporter in muscle from insulin-resistant patients.

Authors:  G L Dohm; C W Elton; J E Friedman; P F Pilch; W J Pories; S M Atkinson; J F Caro
Journal:  Am J Physiol       Date:  1991-03

6.  Insulin sensitivity in adipocytes from subjects with varying degrees of glucose tolerance.

Authors:  J E Foley; P Thuillez; S Lillioja; J Zawadzki; C Bogardus
Journal:  Am J Physiol       Date:  1986-09

7.  Effect of insulin on system A amino acid transport in human skeletal muscle.

Authors:  R C Bonadonna; M P Saccomani; C Cobelli; R A DeFronzo
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

8.  Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man.

Authors:  R A Gelfand; E J Barrett
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

9.  Hyperglycemia decreases glucose uptake in type I diabetes.

Authors:  H Yki-Järvinen; E Helve; V A Koivisto
Journal:  Diabetes       Date:  1987-08       Impact factor: 9.461

10.  Identification of a novel gene encoding an insulin-responsive glucose transporter protein.

Authors:  M J Birnbaum
Journal:  Cell       Date:  1989-04-21       Impact factor: 41.582

View more
  40 in total

Review 1.  Role of plasma membrane transporters in muscle metabolism.

Authors:  A Zorzano; C Fandos; M Palacín
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

2.  Locating the source of hyperglycemia: liver versus muscle.

Authors:  Haoyong Yu; Dequan Zhou; Weiping Jia; ZengKui Guo
Journal:  J Diabetes       Date:  2012-03       Impact factor: 4.006

Review 3.  Alterations of glucose metabolism in type 2 diabetes mellitus. An overview.

Authors:  Riccardo C Bonadonna
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

4.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

5.  Dynamic PET imaging reveals heterogeneity of skeletal muscle insulin resistance.

Authors:  Jason M Ng; Alessandra Bertoldo; Davneet S Minhas; Nicole L Helbling; Paul M Coen; Julie C Price; Claudio Cobelli; David E Kelley; Bret H Goodpaster
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

6.  Assessment of insulin resistance in fructose-fed rats with 125I-6-deoxy-6-iodo-D-glucose, a new tracer of glucose transport.

Authors:  Pascale Perret; Lotfi Slimani; Arnaud Briat; Danièle Villemain; Serge Halimi; Jacques Demongeot; Daniel Fagret; Catherine Ghezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-15       Impact factor: 9.236

7.  A new Michaelis-Menten-based kinetic model for transport and phosphorylation of glucose and its analogs in skeletal muscle.

Authors:  Hsuan-Ming Huang; Faramarz Ismail-Beigi; Raymond F Muzic
Journal:  Med Phys       Date:  2011-08       Impact factor: 4.071

8.  NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise.

Authors:  T B Price; G Perseghin; A Duleba; W Chen; J Chase; D L Rothman; R G Shulman; G I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

Review 9.  Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.

Authors:  Ralph A DeFronzo; Luke Norton; Muhammad Abdul-Ghani
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

Review 10.  Pathogenesis of insulin resistance in skeletal muscle.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Biomed Biotechnol       Date:  2010-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.